+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Prostacyclin"

Treprostinil Palmitil Emerging Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

Treprostinil Palmitil Emerging Drug Insight and Market Forecast - 2032

  • Drug Pipelines
  • December 2022
  • 30 Pages
  • Global
From
Orenitram Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

Orenitram Drug Insight and Market Forecast - 2032

  • Drug Pipelines
  • December 2022
  • 30 Pages
  • Global
From
Treprostinil sodium Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

Treprostinil sodium Drug Insight and Market Forecast - 2032

  • Drug Pipelines
  • December 2022
  • 30 Pages
  • Global
From
Disease Analysis: Pulmonary Hypertension - Product Thumbnail Image

Disease Analysis: Pulmonary Hypertension

  • Drug Pipelines
  • April 2021
  • 78 Pages
  • Global
Tyvaso - Product Thumbnail Image

Tyvaso

  • Report
  • October 2018
  • 17 Pages
  • Global
From
Uptravi - Product Thumbnail Image

Uptravi

  • Report
  • October 2018
  • 18 Pages
  • Global
From
ralinepag - Product Thumbnail Image

ralinepag

  • Report
  • October 2018
  • 15 Pages
  • Global
From
Remodulin - Product Thumbnail Image

Remodulin

  • Report
  • October 2018
  • 15 Pages
  • Global
From
Orenitram - Product Thumbnail Image

Orenitram

  • Report
  • October 2018
  • 20 Pages
  • Global
From
Global Pulmonary Arterial Hypertension Drugs Market 2023-2027 - Product Thumbnail Image

Global Pulmonary Arterial Hypertension Drugs Market 2023-2027

  • Report
  • March 2023
  • 172 Pages
  • Global
From
From
From
From
esuberaprost - Product Thumbnail Image

esuberaprost

  • Report
  • October 2018
  • 17 Pages
  • Global
From
From
Loading Indicator

Prostacyclin is a type of cardiovascular drug used to treat a variety of conditions, including pulmonary arterial hypertension, deep vein thrombosis, and coronary artery disease. It works by inhibiting platelet aggregation and reducing the risk of blood clots. Prostacyclin is typically administered intravenously or subcutaneously, and is available in both generic and branded forms. It is also used in combination with other drugs to treat certain conditions. The prostacyclin market is highly competitive, with a number of companies offering products for the treatment of cardiovascular diseases. These companies include Actelion Pharmaceuticals, Bayer AG, GlaxoSmithKline, Merck & Co., Novartis AG, Pfizer Inc., and Sanofi. Show Less Read more